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Abstract: Stress and starvation causes bacterial cells to activate the stringent response. This results in
down-regulation of energy-requiring processes related to growth, as well as an upregulation of genes
associated with survival and stress responses. Guanosine tetra- and pentaphosphates (collectively
referred to as (p)ppGpp) are critical for this process. In Gram-positive bacteria, a main function of
(p)ppGpp is to limit cellular levels of GTP, one consequence of which is reduced transcription of genes
that require GTP as the initiating nucleotide, such as rRNA genes. In Streptomycetes, the stringent
response is also linked to complex morphological differentiation and to production of secondary
metabolites, including antibiotics. These processes are also influenced by the second messenger
c-di-GMP. Since GTP is a substrate for both (p)ppGpp and c-di-GMP, a finely tuned regulation of
cellular GTP levels is required to ensure adequate synthesis of these guanosine derivatives. Here,
we discuss mechanisms that operate to control guanosine metabolism and how they impinge on the
production of antibiotics in Streptomyces species.
Keywords: c-di-GMP; guanosine and (p)ppGpp; purine salvage; secondary metabolism;
Streptomycetes; stringent response
1. Introduction
Bacteria experience constant challenges, either in the environment or when infecting a host. They
utilize various mechanisms to survive such stresses, which may include changes in temperature, pH,
or oxygen content as well as limited access to carbon or nitrogen sources. A stress response that is
mobilized to deal with events such as nutrient limitation is the stringent response. The purpose of
this response is to focus cellular resources on survival, as opposed to growth [1]. To achieve this
outcome, bacteria synthesize the hyperphosphorylated nucleotides guanosine pentaphosphate and
guanosine tetraphosphate, collectively called (p)ppGpp, from GTP/GDP and ATP. Based on the critical
role of (p)ppGpp, it is also called an alarmone, as it responds to starvation or stress and conveys
such distressing circumstances to the cellular machineries in order to conserve resources. Exposure
to challenging environmental conditions may also induce formation of biofilms, protective bacterial
communities that confer a number of fitness advantages, including resistance to nutrient deprivation
or antimicrobial agents. The second messenger cyclic-di-GMP (c-di-GMP), which is synthesized from
two molecules of GTP, is intimately involved in the switch between a motile planktonic lifestyle
and a sessile biofilm community in unicellular bacteria [2]. In multicellular Actinomycetes, such as
Streptomyces spp., c-di-GMP is involved in controlling developmental processes [3]. Collectively,
these signaling molecules require the presence of purines to sustain their synthesis under conditions of
stress and starvation, circumstances under which the bacterial cell must conserve essential nutrients.
Purine salvage pathways are, therefore, expected to be important for the generation of substrates
for (p)ppGpp and c-di-GMP synthesis. Additionally, members of the genus Streptomyces respond to
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changes in environmental conditions by a morphological differentiation and multicellular development
that may be closely tied to their production of secondary metabolites, including a wide range of
antibiotics. Indeed, two thirds of clinically relevant antibiotics such as chloramphenicol, streptomycin,
and tetracycline are synthesized by Streptomyces spp. [4]. In this review, we discuss how purine
metabolism affects antibiotic production, with an emphasis on the stringent response.
2. Stringent Response and Morphological Differentiation
Nutrient limitation or starvation induces the stringent response in the vast majority of bacteria.
This response was first described in Escherichia coli and shown to involve reduced accumulation of stable
RNAs (rRNA and tRNA); this stringent response was ‘relaxed’ by mutation in the gene accordingly
named relA. Stringent response depends on a transient increase in the level of (p)ppGpp, also known
as the magic spot [5]. Members of the RSH (RelA/SpoT Homolog) protein superfamily are responsible
for (p)ppGpp synthesis from ATP and either GTP or GDP and for the degradation of (p)ppGpp to GTP
or GDP and pyrophosphate, with some members possessing both enzymatic functions. The activity
of different RSH family proteins is controlled by distinct mechanisms, including interaction with
idling ribosomes in many cases, allowing responses to various stresses [1]. The stringent response
may be initiated by limitation of nutrients such as amino acids, nitrogen, phosphorous, and carbon
sources. Once (p)ppGpp accumulates, it exerts global changes designed to downregulate transcription
of genes linked to growth (e.g., ribosome biogenesis) and upregulation of genes required for survival
(e.g., nutrient acquisition and stress responses), and it also directly binds a number of proteins to
regulate their activity [6]. While specific binding targets may differ between Gram-negative and
Gram-positive species, (p)ppGpp has been shown to regulate replication, transcription, translation and
GTP biosynthesis by binding to proteins that participate in these processes, including DNA primase,
RNA polymerase, small GTPases, enzymes involved in purine biosynthesis, and transcriptional
regulators [7–11].
Considerable differences exist between bacterial species with regard to both the mode of action
and metabolism of (p)ppGpp. In Gram-negative species such as E. coli, ribosomes sense the uncharged
tRNAs at the ribosomal A site during amino acid starvation, causing protein synthesis to stall and
resulting in the activation of RelA [12]. This leads to synthesis of (p)ppGpp, which acts as an allosteric
regulator of RNA polymerase. The (p)ppGpp binds together with the regulatory protein DksA;
this leads to inhibition of transcription from stable RNA promoters and promoters driving expression
of genes encoding, for example, ribosomal proteins, and it mediates an activation of genes critical for
cell survival [13,14]. This mechanism is likely to be conserved among other proteobacteria [14].
The stringent response in Gram-positive bacteria is not mediated by direct binding of (p)ppGpp to
RNA polymerase [15,16]. In Bacillus subtilis, (p)ppGpp regulates intracellular GTP levels, even during
normal growth, and dysregulated GTP homeostasis leads to cell death [17,18]. Two mechanisms
contribute to the observed reduction in GTP levels during the stringent response, namely, consumption
of GTP for the purpose of (p)ppGpp synthesis and inhibition of GTP biosynthesis. GTP can be
synthesized by both expensive de novo and less resource-demanding salvage pathways, and (p)ppGpp
binds directly to several proteins that participate in these pathways to inhibit their activity [10,18].
Figure 1 summarizes purine metabolism, identifying key regulated enzymes participating in synthesis
of GTP; de novo synthesis initiated by GuaB-catalyzed conversion of inosine monophosphate (IMP) to
XMP, or formation of XMP by purine salvage, which requires xanthine dehydrogenase (Xdh). As a
consequence of reduced cellular GTP levels, transcription from genes whose initiating nucleotide is
GTP is decreased, thereby accounting for the reduced accumulation of stable RNAs [15]. Expression of
other genes is affected indirectly by the reduced levels of GTP, for example, by favoring transcription
of genes whose initiating nucleotide is ATP [19].
Two proteins, RelA and RSH, participate in (p)ppGpp metabolism in Streptomyces spp., likely with
a division of labor in which RelA and RSH respond to amino acid/glucose starvation and phosphate
starvation, respectively [20–22]. Starvation of Streptomyces spp. results in elevated levels of (p)ppGpp
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as well as a reduced GTP pool, as also seen in B. subtilis, accompanied by reduced transcription of rRNA
genes [23–26]. For example, S. clavuligerus in which relA is inactivated fails to synthesize (p)ppGpp
and maintains steady levels of GTP during growth, whereas wild-type cells exhibit an approximately
three-fold decrease in GTP levels as (p)ppGpp accumulates [27]. A similar (p)ppGpp-dependent
decrease in cellular GTP levels was previously demonstrated in S. griseus during nutritional shift-down,
and it was attributed to ppGpp-mediated inhibition of IMP dehydrogenase (GuaB; Figure 1) [28].
Starvation also elicits a complex morphological differentiation in Streptomycetes, a process that
involves formation of aerial hyphae and unicellular spores for dispersal, and this differentiation may
be accompanied by production of bioactive secondary metabolites. Erection of aerial hyphae requires
the bld (bald) gene products, while differentiation of aerial hyphae into spores requires the whi (white)
gene products [29]. The transcriptional regulator BldD controls a large number of genes, many of
which are involved in differentiation and antibiotic production [3].
The secondary messenger c-di-GMP, which is synthesized from two molecules of GTP by
diguanylate cyclases and degraded by phosphodiesterases, also participates in differentiation. The two
S. coelicolor proteins RmdA and RmdB possess phosphodiesterase activity and the rmdA-rmdB double
mutant accumulates three-fold higher levels of c-di-GMP and is completely deficient in aerial hyphae
formation [30]. Deficiency in generation of aerial mycelium is also a characteristic of S. coelicolor deleted
for cdgB, which encodes a diguanylate cyclase, and of cells over-expressing cdgB; cdgB over-expression
also inhibits formation of the antibiotic actinorhodin [31]. Expression of cdgB is controlled by BldD;
notably, DNA binding by BldD is activated by direct binding of c-di-GMP, leading to repression of the
BldD-controlled sporulation genes during vegetative growth [32].
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intermediate AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) accumulates in presence of 
dihydrofolate reductase inhibitors [33]. Intermediates in salvage pathways are outlined in purple. In 
some species, guanine, xanthine, and hypoxanthine are converted to the corresponding 
mononucleotides by different enzymes. Xdh can initiate degradation of purines (gray). RelA/SpoT 
Homolog (RSH) family enzymes are responsible for (p)ppGpp synthesis and hydrolysis, while 
diguanylate cyclase (DGC) synthesizes c-di-GMP (red). 
Figure 1. Overview of purine etabolis . The de novo biosynthesis (turquoise) starts ith
phosphoribosyl pyrophosphate (PRPP) and ends with inosine monophosphate (IMP); the intermediate
AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) accumulates in presence of dihydrofolate
reductase inhibitors [33]. Intermediates in salvage pathways are outlined in purple. In some species,
guanine, xanthine, and hypoxanthine are converted to the corresponding mononucleotides by different
enzymes. Xdh can initiate degradation of purines (gray). RelA/SpoT Homolog (RSH) family enzymes
are responsible for (p)ppGpp synthesis and hydrolysis, while diguanylate cyclase (DGC) synthesizes
c-di-GMP (red).
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3. Secondary Metabolism in Streptomyces
Members of this genus produce numerous antibiotics or secondary metabolites that are
commercially or clinically relevant. These natural products possess, for example, antibacterial,
antiviral, anti-tumor, and anti-fungal properties [4]. Secondary metabolites are produced in response to
environmental conditions, including starvation or growth of other nearby organisms that may belong
to the same or different bacterial genera, or to different species such as plants or fungi; such compounds
are therefore thought to furnish the producer with a competitive advantage [34]. Under laboratory
conditions, many of the gene clusters that encode proteins involved in generation of natural products
are silent. Efforts to elicit their expression by co-culturing Streptomyces spp. with various other
microbes or by addition of natural and synthetic chemicals have been implemented, and this has
resulted in the identification of numerous antibiotics [35]. Combining drug resistant mutations also
resulted in activation of antibiotic gene clusters [36,37]. Inducers of secondary metabolism are likely
to act indirectly through intracellular signaling, including the generation of alarmones. Since many
gene clusters have resisted efforts to elicit their expression during laboratory conditions, Streptomyces
spp. (and other bacterial species known for production of bioactive secondary metabolites, such as
Burkholderia spp. [38]) are predicted to constitute a valuable resource for discovery of novel biologically
active compounds.
Genes linked to biosynthesis of secondary metabolites generally form very large clusters,
often comprising multiple operons, and analysis of genome sequences suggests that the majority are
species specific [39]. For instance, S. coelicolor strain A3(2) produces several compounds, including the
red-pigmented undecylprodigiosin (RED, a member of the prodiginine family of bacterial alkaloids),
the deep blue polyketide actinorhodin (ACT), and methylenomycin (Figure 2; reviewed in [40]),
while S. griseus produces streptomycin, S. virginia produces virginiamycin, S. natalensis produces
pimaricin, and S. avermitilis produces avermectin [40]. The antibiotic biosynthetic gene clusters often
include regulatory genes referred to as cluster-situated regulators (CSR) [40,41]. The CSRs may
directly regulate the transcription of the corresponding antibiotic gene cluster or they may control
antibiotic production indirectly through other mechanisms [40]. Activation of antibiotic synthesis is
complex and may involve multiple regulators, including factors that affect both antibiotic production
and differentiation such as BldD, and it may require a variety of signals, including accumulation of
(p)ppGpp and c-di-GMP.
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4. Link Between Purine Salvage and Production of Guanosine Nucleotide Second Messengers
While (p)ppGpp was first identified under conditions of amino acid starvation, it has since
been associated with a number of other stress conditions, most notably conditions faced by bacterial
pathogens when they infect a host [42]. Since guanosine nucleotide second messengers are synthesized
from GDP or GTP (and at the expense of ATP hydrolysis in case of (p)ppGpp), the enzymes required
for purine de novo synthesis or salvage are critical for the generation of these second messengers.
Direct links between activity of purine metabolic enzymes and (p)ppGpp accumulation have been
documented in several bacterial species, including the effects on virulence in the case of pathogens.
4.1. Cellular Levels of GTP and (p)ppGpp are Inter-Dependent
De novo purine biosynthesis involves the assembly of the purine ring on phosphoribosyl-
pyrophosphate (PRPP) to generate inosine monophosphate (IMP), which is the precursor to both AMP
and GMP (Figure 1) [43,44]. Purine bases or nucleotides, including those acquired from exogenous
sources, may be inter-converted using salvage pathways. Activity of a number of enzymes in
these pathways has been reported to affect the generation of (p)ppGpp, including hypoxanthine
guanine phosphoribosyl transferase (HGPRT), which salvages guanine, xanthine, and hypoxanthine
nucleobases by converting them to the corresponding mononucleotides, IMP dehydrogenase (GuaB),
which catalyzes the committed step in de novo GMP biosynthesis, GMP synthetase (GuaA), and xanthine
dehydrogenase (Xdh). Xdh converts hypoxanthine to xanthine, thus favoring the conversion of adenine
to guanine, and it can divert purines away from salvage pathways and towards degradation by
catalyzing the oxidation of xanthine to urate [45]. For example, guaA and guaB mutants of the Lyme
disease pathogen Borrelia burgdorferi fail to infect a mouse model, illustrating that purine metabolic
enzymes play an important role in virulence [46]. Lacking enzymes involved in de novo purine
biosynthesis, this bacterium in addition depends on transport proteins to salvage purines from the
host [47]. Both (p)ppGpp and c-di-GMP play a vital role during starvation and survival in the tick
host, and failure to synthesize these messengers reduces persistence [48,49]. In Sinorhizhobium meliloti,
(p)ppGpp synthesis is increased upon carbon or nitrogen starvation, concomitant with an increase in
the transcript levels of xdh. This indicates that the xdh gene product is linked to synthesis of (p)ppGpp
during starvation [50]. Consistent with this interpretation, xdh expression is also increased in stationary
phase in S. coelicolor, whereas inhibition of Xdh with allopurinol attenuates (p)ppGpp production [51].
In Listeria monocytogenes, both hgprt and relA mutants are incapable of synthesizing (p)ppGpp and fail
to cause infection in mice [52]. Evidently, the enzymes of purine metabolism are critical for maintaining
the requisite levels of guanosine nucleotide second messengers.
A feedback response in which (p)ppGpp negatively controls activity of purine metabolic enzymes
also exists. As noted above, S. griseus GuaB is inhibited by ppGpp, which accounts for reduced cellular
levels of GTP during stringent response (Figure 3) [28]. In B. subtilis, (p)ppGpp inhibits several GTP
biosynthesis enzymes, but primarily HGPRT and Gmk, which converts GMP to GDP, in order to
regulate the GTP levels in the cell [9]; in absence of (p)ppGpp, excess GTP leads to cell death [18].
Staphylococcus aureus HGPRT and Gmk are also direct targets for (p)ppGpp, suggesting a conserved
regulatory mechanism [10]. By contrast, Gmk is not specifically inhibited by (p)ppGpp in Enterococcus
faecalis, whereas HGPRT is [53]. In addition, HPRT/GPRT were recently confirmed as physiologically
relevant targets of (p)ppGpp in E. coli as well, suggesting that direct regulation of purine metabolic
enzymes by (p)ppGpp is not unique to Gram-positive species [8]. That (p)ppGpp targets different
enzymes in various bacterial species speaks to distinct mechanisms for control of GTP homeostasis.
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Figure 3. Summary of link between guanosine metabolism and antibiotic production. During vegetative
growth, cellular concentrations of GTP are high, but maintained by (p)ppGpp-mediated inhibition
of GTP biosynthesis, most likely direct inhibition of GuaB. Under these conditions, c-di-GMP is
produced, and it binds BldD to form a complex, which represses bld and whi genes. Under stress
conditions, (p)ppGpp accumulates, resulting in efficient inhibition of GTP biosynthesis. However, high
levels of (p)ppGpp also mediate an increase in Xdh production, averting excessive depletion of GTP.
Reduced production of c-di-GMP results in derepression of bld and whi genes, leading to morphological
differentiation. The accumulation of (p)ppGpp generally leads to production of secondary metabolites,
including antibiotics. The role of BldD in antibiotic production remains to be fully elucidated.
4.2. Production of Xdh As a Mechanism to Promote Purine salvage
Control of cellular GTP levels is thought to be a primary function of (p)ppGpp in Gram-positives,
guarding against excess GTP accumulation during balanced growth and effecting a decrease during the
stringent response [9,18,53]. However, excessive depletion of GTP is also deleterious, and mechanisms
exist that favor synthesis of guanosine nucleotides. In S. coelicolor, xanthine dehydrogenase regulator
(XdhR) represses expression of the xdh operon; XdhR binds ppGpp (and with lower affinity to GTP),
a result of which is attenuated DNA binding and increased expression of the xdhABC gene cluster
during the stringent response [51]. This mode of regulation would bias purine salvage pathways
towards production of guanosine nucleotides, particularly during stringent response when de novo
pathways are downregulated and the bacteria are dependent upon salvage pathways. The ~0.2 mM
affinity of ppGpp for XdhR suggests that xdh expression (and hence GTP synthesis) will be induced
when (p)ppGpp accumulates to mM concentrations; under these conditions, (p)ppGpp-mediated
repression of target enzymes in the purine biosynthesis pathways would be efficient, and production
of Xdh may avert excessive depletion of GTP. If (p)ppGpp preferentially inhibits GuaB, as reported
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in S. griseus [28], then GTP production would depend on synthesis of XMP via xanthine (Figure 1),
rationalizing the need for (p)ppGpp-dependent control of xdh expression (Figure 3).
The xdhR-xdhABC gene locus is not conserved in B. subtilis, where instead expression of xdh is
induced in the presence of hypoxanthine [54]. By contrast, hypoxanthine is not a ligand for S. coelicolor
XdhR [51]. This may reflect that B. subtilis Xdh has a primary role in purine catabolism, whereas
S. coelicolor Xdh activity is more important for GTP homeostasis. Consistent with this interpretation,
the catabolism of xanthine to urate appears to be disfavored in Agrobacterium fabrum during the
stringent response when (p)ppGpp accumulates and xdh expression is increased; A. fabrum encodes a
locus that is homologous to the xdhR-xdhABC gene cluster found in Streptomyces spp. [55]. Furthermore,
an S. coelicolor xdhR mutant, which overproduces Xdh, is defective in forming aerial mycelium
and spores and it overproduces the antibiotic ACT [56–58]; the ∆xdhR strain does not express whi
genes, which are important for sporulation, likely on account of increased (p)ppGpp synthesis and
dysregulated GTP homeostasis.
A. fabrum XdhR binds c-di-GMP with even higher affinity than ppGpp [51]. As noted above,
c-di-GMP is also involved in morphological differentiation and antibiotic production in Streptomyces
spp., and it activates DNA binding by the key regulator BldD. S. coelicolor XdhR likewise responds to
c-di-GMP by attenuated DNA binding (Sivapragasam and Grove, unpublished), which may favor
synthesis of GTP to sustain production of secondary messengers that derive from GTP. Taken together,
we propose that regulation of purine metabolism and GTP homeostasis in Streptomycetes is distinct
from that reported in B. subtilis and that these processes need to be carefully managed to maintain the
optimal synthesis of guanosine nucleotide second messengers.
Starvation of nutrients, stationary phase, and slow growth leads to degradation of stable RNAs,
rRNA and tRNA. These RNAs, which are typically not degraded during balanced growth, account for
the vast majority of total RNA, and they represent a valuable source of nutrients [59]. For instance,
extensive degradation (>90%) of the 23S rRNA and 16S rRNA occurs in Salmonella strains when they
reach stationary phase [60]. A similar degradation of rRNA is observed in a relA mutant of E. coli
following nutrient starvation [61]. Even during slow growth, almost 70% of the rRNA that is newly
synthesized is degraded. This degradation is considered to be a vital survival strategy as it furnishes
the bacteria with a source of nucleotides for salvage pathways during stress or starvation.
5. Guanosine Metabolism Impinges on Antibiotic Production
Analysis of annotated Streptomyces genomes suggests the presence of >20 species-specific gene
clusters implicated in synthesis of secondary metabolites per genome, many of them antibiotics [39].
Production of many such natural products is coordinated with morphological differentiation, however,
regulatory mechanisms are complex, and (p)ppGpp has been reported to serve as both negative and
positive regulator.
5.1. Production of Actinorhodin (ACT) and Undecylprodigiosin (RED)
Production of antibiotics such as ACT and RED (Figure 2) in S. coelicolor generally takes place in
stationary phase when (p)ppGpp accumulates (Figure 3) and genes encoding the biosynthetic enzymes
are activated by cluster-situated regulators ActII-ORF4 and RedD, respectively [62,63]. Inactivation of
relA in S. coelicolor A2(3) abolishes (p)ppGpp synthesis and production of both ACT and RED under
nitrogen-limiting conditions, and this correlates with the reduced accumulation of both actII-ORF4 and
redD transcripts (Table 1) [64]. Under conditions of nutrient sufficiency, induced production of (p)ppGpp
results in activation of actII-ORF4, but not redD, indicating that accumulation of (p)ppGpp per se does
not induce RED production [21,65]. While inactivation of either relA or rshA in S. coelicolor M600 leads
to a complete lack of ACT production in batch culture, RED production is higher than in wild-type
cells [20]. Based on the analysis of (p)ppGpp levels and antibiotic production in a strain carrying a
mutation in the principal sigma factor (a mutation that was speculated to reduce levels of substrates
for (p)ppGpp synthesis), it was inferred that (p)ppGpp-mediated induction of antibiotic production
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is extremely sensitive to differences in cellular (p)ppGpp pools [66]. In S. coelicolor and S. griseus,
the cyclic AMP (cAMP)-binding protein EshA is essential for ensuring adequate (p)ppGpp synthesis
by mechanisms that remain unclear and this, in turn, is required for (p)ppGpp-mediated control of
GTP levels. EshA is therefore important for morphological differentiation and ACT/streptomycin
production [67]. This analysis also concluded that finely tuned (p)ppGpp accumulation is essential for
ensuring antibiotic production.
Table 1. Examples of factors involved in antibiotic production in Streptomyces spp. that are linked to
stress response or GTP synthesis.
Species Factor Link to Guanosine Metabolism or Antibiotic Production
S. coelicolor RelA (p)ppGpp synthesis, ACT/RED production [64]
S. coelicolor RelC (RplK) (p)ppGpp synthesis, ACT/RED production [68]
S. coelicolor EshA (p)ppGpp synthesis, ACT production [67]
S. coelicolor XdhR Xdh and (p)ppGpp synthesis, ACT production [51,56,58]
S. coelicolor RmdA, RmdB c-di-GMP degradation, ACT production [30]
S. coelicolor CdgA, CdgB c-di-GMP synthesis, ACT production [31]
S. antibioticus RelA (p)ppGpp synthesis, actinomycin production [69]
S. antibioticus RelC (p)ppGpp synthesis, actinomycin production [70]
S. clavuligerus RelA (p)ppGpp synthesis, clavulanic acid and cephamycin C production [27,71]
S. griseus Rel
GuaA
(p)ppGpp synthesis, streptomycin production [23]
Transcription of actII-ORF4 is under control of numerous regulators, whereas redD is activated by
RedZ; redZ expression, however, is controlled by some of the same factors that regulate actII-ORF4
expression (reviewed in [40]). The transcriptional regulator XdhR, which was previously shown
to control expression of the xdh gene cluster by mediating a (p)ppGpp-dependent increase in xdh
expression during nutrient limitation and stationary phase [51,56], also binds the promoter regions of
actII-ORF4 and actII-ORF1. The gene actII-ORF1 encodes another cluster-situated regulator of ACT
biosynthesis. The binding of XdhR leads to the repression of genes encoding ACT biosynthetic enzymes
and hence production of ACT in S. coelicolor M145 [58]. Since (p)ppGpp is a ligand for XdhR, entry
into stationary phase or stringent response would be expected to lead to dissociation of XdhR from the
actII-ORF4 and actII-ORF1 promoters, thus facilitating ACT biosynthesis. Accordingly, XdhR directly
links regulation of purine metabolism with (p)ppGpp–mediated control of antibiotic production.
5.2. Production of Other Antibiotics
(p)ppGpp has also been implicated in controlling the antibiotic production in other Streptomyces
spp. For example, an S. antibioticus relA mutant is deficient in (p)ppGpp synthesis and actinomycin
production, a deficiency that is not alleviated by growth under phosphate-limiting conditions [69].
In S. griseus, inhibition of GMP synthetase/GuaA (and hence GTP and (p)ppGpp production) by
addition of decoyinine leads to formation of aerial mycelium, but a decrease in the production of
streptomycin [23]. A rel mutant (tentatively identified as a relC mutant) fails to accumulate (p)ppGpp in
response to nutrient limitation, and it is deficient in both formation of aerial mycelium and submerged
spores and in production of enzymes required for streptomycin biosynthesis. In this rel mutant,
the addition of decoyinine is accompanied by a marked reduction in cellular GTP levels and it restores
the generation of submerged spores; this indicates that morphological differentiation is initiated when
GTP levels decrease, but that streptomycin biosynthesis requires (p)ppGpp.
In S. clavuligerus, inactivation of relA leads to the expected failure to accumulate (p)ppGpp and an
inability to sporulate. However, production of clavulanic acid and cephamycin C and transcription of
biosynthetic genes is increased in the rel mutant, indicating that antibiotic production is negatively
regulated by (p)ppGpp [27]. Curiously, the production of these antibiotics in a relA mutant strain also
appears to depend on strain background and/or growth media as reflected in a separate study in which
an S. clavuligerus relA disruptant strain was deficient in antibiotic production [71]. The general role of
Antibiotics 2019, 8, 76 9 of 13
(p)ppGpp in eliciting an upregulation of antibiotic production in a number of bacterial species has
also motivated efforts towards metabolic engineering by expressing a (p)ppGpp synthetase. In the
actinomycete Saccharopolyspora erythraea, this approach yields increased production of erythromycin,
but only in a wild-type strain and not in an industrial strain, which already exhibits elevated (p)ppGpp
levels [72].
5.3. Regulation of Antibiotic Production by c-di-GMP
Both (p)ppGpp and c-di-GMP affect morphological differentiation and regulation of antibiotic
production. As noted above, the master regulator BldD represses genes involved in formation of aerial
hyphae (the bld genes) and sporulation (the whi genes) during vegetative growth, and this occurs
when BldD binds c-di-GMP [29,32]. Accordingly, c-di-GMP is required for repression of the BldD
regulon, and overexpression of the diguanylate cyclases CdgA or CdgB blocks formation of aerial
hyphae [3,31]. BldD directly controls expression of cdgA and cdgB, a regulatory mechanism that may
prevent excessive accumulation of c-di-GMP. A bldD mutant likewise exhibits a bald phenotype as it
bypasses formation of aerial hyphae and sporulates prematurely [32]. The production of antibiotics
correlates with these morphological phenotypes as both overexpression of diguanylate cyclases and
inactivation of bldD leads to a defect in ACT production [73]. BldD controls activity of the adpA gene
(bldH in S. coelicolor), which encodes an AraC-family activator of actII-ORF4 and redD expression,
and it binds directly to nsdA, which encodes a repressor of ACT production [3,74]. Accordingly, either
absence of BldD or hyper-activation of its DNA binding by excess c-di-GMP is likely to result in failure
to control expression of cluster-situated activators of ACT and RED. Since XdhR also binds actII-ORF4,
and since DNA binding by XdhR is attenuated by c-di-GMP (Sivapragasam and Grove, unpublished),
we speculate that XdhR may also participate in fine-tuning of actII-ORF expression in response to
cellular levels of c-di-GMP.
6. Conclusions
Antibiotic production in Streptomyces spp. is linked to the stringent response and morphological
differentiation (Figure 3). During vegetative growth, cellular GTP levels are high, conditions
under which synthesis of c-di-GMP would be favored, and BldD–c-di-GMP represses bld and whi
genes. As (p)ppGpp levels increase, the attendant decrease in cellular GTP levels is associated with
de-repression of bld and whi genes and erection of aerial hyphae and sporulation. By contrast, antibiotic
production generally occurs as a direct consequence of (p)ppGpp production, with BldD–c-di-GMP
playing a poorly understood role in controlling expression of several regulators of antibiotic biosynthetic
genes. As both signaling molecules are synthesized from GTP, purine metabolism affects their
accumulation, yet GTP homeostasis is likely controlled by distinct mechanisms in different bacterial
species, as evidenced for example by the specific purine metabolic enzymes that are direct targets for
(p)ppGpp. Notably, recent evidence suggests that the transcription factor XdhR furnishes a direct
link between purine salvage and ACT production. Accumulation of (p)ppGpp is associated with
increased production of Xdh, as (p)ppGpp attenuates binding of XdhR to the xdh promoter; this would
circumvent the (p)ppGpp-mediated inhibition of GuaB and allow GTP production to proceed via
xanthine and XMP. Under these conditions, XdhR-mediated repression of actII-ORF4 would also be
relieved by (p)ppGpp. Evidently, finely tuned mechanisms operate to control guanosine metabolism,
in turn impinging on production of antibiotics.
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